Vertex Pharmaceuticals Incorporated / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €14.71B +10.2% €6.20B +8.8% 42.2% -0.0054 pp N/A N/A
    (estimated) €13.35B +8.5% €5.70B +11.3% 42.7% +0.011 pp €6.56B +24.1% 49.2% +0.062 pp
    (estimated) €12.30B +8.8% €5.12B +12.6% 41.6% +0.014 pp €5.29B +10.4% 43.0% +0.0062 pp
    (estimated) €11.30B +10.4% €4.55B +14.6% 40.2% +0.015 pp €4.79B +25.7% 42.4% +0.052 pp
    (estimated) €10.23B +8.9% €3.97B -968.8% 38.8% +0.44 pp €3.81B -2,391.2% 37.2% +0.39 pp
    €9.40B +11.7% -€456.84M -114.8% -4.9% -0.42 pp -€166.24M -105.1% -1.8% -0.40 pp
    €8.42B +10.5% €3.09B +9.0% 36.7% -0.0052 pp €3.24B -12.4% 38.5% -0.10 pp
    €7.62B +17.9% €2.83B +41.8% 37.2% +0.063 pp €3.70B +50.6% 48.5% +0.11 pp
    €6.46B +22.1% €2.00B -13.6% 30.9% -0.13 pp €2.46B -18.1% 38.0% -0.19 pp
    €5.29B +49.1% €2.31B +130.4% 43.7% +0.15 pp €3.00B +113.6% 56.6% +0.17 pp
    €3.55B +36.6% €1.00B -43.9% 28.3% -0.41 pp €1.40B +20.4% 39.5% -0.053 pp
    €2.60B +22.5% €1.79B +695.8% 68.8% +0.58 pp €1.16B +23.7% 44.8% +0.0044 pp
    €2.12B +46.2% €224.74M -335.1% 10.6% +0.17 pp €941.97M +277.3% 44.4% +0.27 pp
    €1.45B +64.9% -€95.57M -79.9% -6.6% +0.47 pp €249.63M -191.4% 17.2% +0.48 pp
    €880.53M +77.9% -€476.04M -24.4% -54.1% +0.73 pp -€273.06M -30.7% -31.0% +0.49 pp
    €495.07M -52.1% -€629.95M +66.0% -127.2% -0.91 pp -€394.06M +260,915.8% -79.6% -0.80 pp
    €1.03B -20.6% -€379.59M +315.8% -36.7% -0.30 pp -€150.97K -100.1% -0.0% -0.22 pp
    €1.30B +8.3% -€91.29M -461.9% -7.0% -0.091 pp €289.13M +42.2% 22.2% +0.053 pp
    €1.20B +883.9% €25.23M -103.9% 2.1% +5.3 pp €203.28M -139.9% 16.9% +4.3 pp
    €122.29M +40.5% -€643.66M +17.6% -526.3% +1.0 pp -€509.54M +47.8% -416.7% -0.21 pp
    €87.04M -41.9% -€547.23M +39.5% -628.7% -3.7 pp -€344.67M +108.0% -396.0% -2.9 pp
    €149.70M -11.8% -€392.23M +17.5% -262.0% -0.65 pp -€165.73M -11.7% -110.7% -0.0013 pp
    €169.75M -8.0% -€333.74M +89.1% -196.6% -1.0 pp -€187.70M -2,313.4% -110.6% -1.2 pp
    €184.54M +34.5% -€176.47M +1.7% -95.6% +0.31 pp €8.48M -106.4% 4.6% +1.0 pp
    €137.23M +56.6% -€173.50M +22.4% -126.4% +0.35 pp -€132.29M +19.6% -96.4% +0.30 pp
    €87.61M +48.6% -€141.80M -15.5% -161.8% +1.2 pp -€110.60M -13.7% -126.2% +0.91 pp
    €58.97M -57.1% -€167.83M +81.2% -284.6% -2.2 pp -€128.17M +292.2% -217.3% -1.9 pp
    €137.40M -3.8% -€92.65M +64.0% -67.4% -0.28 pp -€32.69M -183.6% -23.8% -0.51 pp
    €142.86M +114.4% -€56.49M +67.0% -39.5% +0.11 pp €39.09M -1,068.6% 27.4% +0.33 pp
    €66.64M +26.8% -€33.83M -3.3% -50.8% +0.16 pp -€4.04M -69.7% -6.1% +0.19 pp
    €52.54M +38.7% -€34.97M +23.9% -66.6% +0.080 pp -€13.31M -32.8% -25.3% +0.27 pp
    €37.87M +1.4% -€28.23M +67.2% -74.5% -0.29 pp -€19.79M +582.4% -52.3% -0.44 pp
    €37.36M +229.3% -€16.89M -50.5% -45.2% +2.6 pp -€2.90M -90.6% -7.8% +2.7 pp
    €11.34M -39.8% -€34.12M +86.0% -300.8% -2.0 pp -€30.96M +242.5% -272.9% -2.2 pp
    €18.85M +12.8% -€18.34M +22.2% -97.3% -0.075 pp -€9.04M -17.2% -48.0% +0.17 pp
    €16.72M -29.7% -€15.01M -980.0% -89.8% -0.97 pp -€10.92M -223.1% -65.3% -1.0 pp
    €23.80M +634.2% €1.71M -123.5% 7.2% +2.3 pp €8.87M -373.7% 37.3% +1.4 pp
    €3.24M +18.8% -€7.25M +66.7% -223.7% -0.64 pp -€3.24M +192.3% -100.0% -0.59 pp
    €2.73M -€4.35M -159.4% -€1.11M -40.6%

    Notifications